Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century

INTRODUCTION: The advent of tyrosine kinase inhibitors has produced 5-year survival of 90 + % for chronic myelocytic leukemia (CML) patients in clinical trials. However, population level survival has been lower, especially in older patients. Here, we examine survival of patients with CML in Germany...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pulte, Dianne, Barnes, Benjamin, Jansen, Lina, Eisemann, Nora, Emrich, Katharina, Gondos, Adam, Hentschel, Stefan, Holleczek, Bernd, Kraywinkel, Klaus, Brenner, Hermann
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848850/
https://ncbi.nlm.nih.gov/pubmed/24499592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-70
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados